Exosomes as actively targeted nanocarriers for cancer therapy

37Citations
Citations of this article
66Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In recent years, it has been found that exosomes can be used as nanocarriers, which can be used in the treatment of tumors by carrying contents. The exosomes are derived from the secretion of the organism’s own cells and are characterized by a phospholipid bilayer structure and a small particle size. These characteristics guarantee that the exosomes can carry a wide range of tumor drugs, deliver the drug to the cancer, and reduce or eliminate the tumor drug band. The toxic side effects were significantly eliminated; meanwhile, the therapeutic effects of the drug on the tumor were remarkably improved. This paper reviewed the strategies and drugs presented by different scholars for the treatment of tumors based on the drugs carried by exosomes.

Cite

CITATION STYLE

APA

Wang, Y., Zhang, Y., Cai, G., & Li, Q. (2020). Exosomes as actively targeted nanocarriers for cancer therapy. International Journal of Nanomedicine. Dove Medical Press Ltd. https://doi.org/10.2147/IJN.S239548

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free